Promise and Challenges of Integrity Oncology

November 24, 2025
12:00PM TO 1:00PM
00
Days
00
Hours
00
Minutes
00
Seconds
Register Now
Dr. Rajagopal Krishnan
Dr. Rajagopal Krishnan

Chief Physician, Dr. Rajagopal\'s Ayur Cancer Care (Centre of Integrative Oncology and Autoimmune Research), Kollam, Kerala

About the Webinar

Integrity Oncology represents an emerging approach in cancer care that emphasizes transparency, ethical decision-making, and data-driven treatment strategies.
Its promise lies in fostering patient trust, enabling more personalized therapies, and ensuring that clinical decisions are grounded in accurate, unbiased evidence. With advancements in genomics, digital health, and real-world data, Integrity Oncology has the potential to significantly improve outcomes and streamline care pathways. However, challenges remain, including data privacy concerns, variability in care standards, and the need for stronger regulatory frameworks to maintain true integrity across systems. Addressing these barriers is essential for realizing the full potential of this transformative model in oncology.

Meet the Speaker

Dr. Rajagopal Krishnan
Dr. Rajagopal Krishnan

Chief Physician, Dr. Rajagopal\'s Ayur Cancer Care (Centre of Integrative Oncology and Autoimmune Research), Kollam, Kerala

Dr. Rajagopal Krishnan is the Chief Physician at Dr. Rajagopal\'s Ayur Cancer Care, a leading Centre for Integrative Oncology and Autoimmune Research in Kollam, Kerala. He is known for his expertise in combining traditional Ayurvedic principles with modern oncology to support holistic cancer care and autoimmune disease management. Dr. Krishnan has extensive clinical experience and is recognized for his patient-centric approach, focusing on individualized treatment plans that enhance overall well-being. His work emphasizes evidence-informed integrative therapies that complement conventional cancer treatments. As a speaker, he brings a unique blend of traditional wisdom, clinical insight, and innovative thinking in integrative oncology.